Terms: = Liver cancer AND AKT1, P31749, RAC-ALPHA, RAC, PRKBA, PKB-ALPHA, PKB, MGC99656, AKT, ENSG00000142208, 207
4231 results:
1. PSMD9 promotes the malignant progression of hepatocellular carcinoma by interacting with c-Cbl to activate EGFR signaling and recycling.
Su Y; Meng L; Ge C; Liu Y; Zhang C; Yang Y; Tian W; Tian H
J Exp Clin Cancer Res; 2024 May; 43(1):142. PubMed ID: 38745188
[TBL] [Abstract] [Full Text] [Related]
2. High expression of SRSF1 facilitates osteosarcoma progression and unveils its potential mechanisms.
Li S; Huang X; Zheng S; Zhang W; Liu F; Cao Q
BMC Cancer; 2024 May; 24(1):580. PubMed ID: 38735973
[TBL] [Abstract] [Full Text] [Related]
3. Nuclear Softness Promotes the Metastatic Potential of Large-Nucleated Colorectal cancer Cells via the ErbB4-akt1-Lamin A/C Signaling Pathway.
Li Y; Li Q; Mu L; Hu Y; Yan C; Zhao H; Mi Y; Li X; Tao D; Qin J
Int J Biol Sci; 2024; 20(7):2748-2762. PubMed ID: 38725859
[TBL] [Abstract] [Full Text] [Related]
4. The prognostic significance and potential mechanism of DBF4 zinc finger in hepatocellular carcinoma.
Wu Z; Zhang L; Li X; Liu L; Kuang T; Qiu Z; Deng W; Wang W
Sci Rep; 2024 May; 14(1):10662. PubMed ID: 38724606
[TBL] [Abstract] [Full Text] [Related]
5. A pathological joint-liver axis mediated by matrikine-activated CD4
Yi J; Zhang H; Bao F; Chen Z; Zhong Y; Ye T; Chen X; Qian J; Tian M; Zhu M; Peng Z; Pan Z; Li J; Hu Z; Shen W; Xu J; Zhang X; Cai Y; Wu M; Liu H; Zhou J; Ouyang H
Signal Transduct Target Ther; 2024 May; 9(1):109. PubMed ID: 38714712
[TBL] [Abstract] [Full Text] [Related]
6. DNAJC24 acts directly with PCNA and promotes malignant progression of LUAD by activating phosphorylation of akt.
Liu D; Zuo R; Liu W; He Y; Wang Y; Yue P; Gong W; Cui J; Zhu F; Luo Y; Qi L; Guo Y; Chen L; Li G; Liu Z; Chen P; Guo H
FASEB J; 2024 May; 38(9):e23630. PubMed ID: 38713100
[TBL] [Abstract] [Full Text] [Related]
7. DCAF1 interacts with PARD3 to promote hepatocellular carcinoma progression and metastasis by activating the akt signaling pathway.
Zhang J; Shi Y; Ding K; Yu W; He J; Sun B
J Exp Clin Cancer Res; 2024 May; 43(1):136. PubMed ID: 38711082
[TBL] [Abstract] [Full Text] [Related]
8. Upregulation of LHPP by saRNA inhibited hepatocellular cancer cell proliferation and xenograft tumor growth.
Bi CQ; Kang T; Qian YK; Kang M; Zeng XH; Li LC
PLoS One; 2024; 19(5):e0299522. PubMed ID: 38696452
[TBL] [Abstract] [Full Text] [Related]
9. YBX1 promotes stemness and cisplatin insensitivity in intrahepatic cholangiocarcinoma via the akt/β-catenin axis.
Shi X; Hu Z; Bai S; Zong C; Xue H; Li Y; Li F; Chen L; Xuan J; Xia Y; Wei L; Shen F; Wang K
J Gene Med; 2024 May; 26(5):e3689. PubMed ID: 38676365
[TBL] [Abstract] [Full Text] [Related]
10. Anti-Tumor Activity and Mechanism of Silibinin Based on Network Pharmacology and Experimental Verification.
Li P; Wang D; Yang X; Liu C; Li X; Zhang X; Liu K; Zhang Y; Zhang M; Wang C; Wang R
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675723
[TBL] [Abstract] [Full Text] [Related]
11. Tumor-Extrinsic Axl Expression Shapes an Inflammatory Microenvironment Independent of Tumor Cell Promoting Axl Signaling in Hepatocellular Carcinoma.
Breitenecker K; Heiden D; Demmer T; Weber G; Primorac AM; Hedrich V; Ortmayr G; Gruenberger T; Starlinger P; Herndler-Brandstetter D; Barozzi I; Mikulits W
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673795
[TBL] [Abstract] [Full Text] [Related]
12. Network toxicology and molecular docking for the toxicity analysis of food contaminants: A case of Aflatoxin B
Chu ZY; Zi XJ
Food Chem Toxicol; 2024 Jun; 188():114687. PubMed ID: 38663764
[TBL] [Abstract] [Full Text] [Related]
13. Wighteone, a prenylated flavonoid from licorice, inhibits growth of SW480 colorectal cancer cells by allosteric inhibition of akt.
Chen X; Ma R; Wu W; Gao R; Shu Y; Dong M; Guo M; Tang D; Li D; Ji S
J Ethnopharmacol; 2024 Aug; 330():118195. PubMed ID: 38641080
[TBL] [Abstract] [Full Text] [Related]
14. Predicting early recurrence after resection of initially unresectable colorectal liver metastases: the role of baseline and pre-surgery clinical, radiological and molecular factors in a real-life multicentre experience.
Moretto R; Germani MM; Borelli B; Conca V; Rossini D; Boraschi P; Donati F; Urbani L; Lonardi S; Bergamo F; Cerma K; Ramondo G; D'Amico FE; Salvatore L; Valente G; Barbaro B; Giuliante F; Di Maio M; Masi G; Cremolini C
ESMO Open; 2024 Apr; 9(4):102991. PubMed ID: 38631269
[TBL] [Abstract] [Full Text] [Related]
15. An exosome mRNA-related gene risk model to evaluate the tumor microenvironment and predict prognosis in hepatocellular carcinoma.
Du Z; Han X; Zhu L; Li L; Castellano L; Stebbing J; Peng L; Wang Z
BMC Med Genomics; 2024 Apr; 17(1):86. PubMed ID: 38627727
[TBL] [Abstract] [Full Text] [Related]
16. [Baicalin induces ferroptosis in HepG2 cells by inhibiting ROS-mediated PI3K/akt/FoxO3a signaling pathway].
Zhou JQ; Li HJ; Zeng YH; Chen HH; Liang WY; Zhang J; Ding FP
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1327-1334. PubMed ID: 38621980
[TBL] [Abstract] [Full Text] [Related]
17. [Bupleuri Radix-Paeoniae Radix Alba medicated plasma exerts effects on HepG2 hepatoma cells by regulating miR-1297/PTEN signaling axis].
Ding L; Wang RY; Zhang F; Wu MS; Chen B; Sun KW
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1073-1081. PubMed ID: 38621914
[TBL] [Abstract] [Full Text] [Related]
18. Potential utility of l-carnitine for preventing liver tumors derived from metabolic dysfunction-associated steatohepatitis.
Lyu J; Okada H; Sunagozaka H; Kawaguchi K; Shimakami T; Nio K; Murai K; Shirasaki T; Yoshida M; Arai K; Yamashita T; Tanaka T; Harada K; Takamura T; Kaneko S; Yamashita T; Honda M
Hepatol Commun; 2024 May; 8(5):. PubMed ID: 38619434
[TBL] [Abstract] [Full Text] [Related]
19. Integrated analyses for identification of a three-gene signature associated with Chaihu Shugan San formula for hepatocellular carcinoma treatment.
Xing JH; Tan RX; Huang FE; Tian N
J Cell Mol Med; 2024 Apr; 28(8):e18211. PubMed ID: 38613352
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic Significance of Iron Metabolism and Immune-Related Genes as Risk Markers in Hepatocellular Carcinoma.
Tang S; Chen H
J Environ Pathol Toxicol Oncol; 2024; 43(3):51-67. PubMed ID: 38608145
[TBL] [Abstract] [Full Text] [Related]
[Next]
